Abstract
The present study was designed to study the interaction of propionic acid and carnitine on oxidative metabolism by isolated rat hepatocytes. Propionic acid (10 mM) inhibited hepatocyte oxidation of [1-14C]-pyruvate (10 mM) by 60%. This inhibition was not the result of substrate competition, as butyric acid had minimal effects on pyruvate oxidation. Carnitine had a small inhibitory effect on pyruvate oxidation in the hepatocyte system (210 +/- 19 and 184 +/- 18 nmol of pyruvate/60 min per mg of protein in the absence and presence of 10 mM-carnitine respectively; means +/- S.E.M., n = 10). However, in the presence of propionic acid (10 mM), carnitine (10 mM) increased the rate of pyruvate oxidation by 19%. Under conditions where carnitine partially reversed the inhibitory effect of propionic acid on pyruvate oxidation, formation of propionylcarnitine was documented by using fast-atom-bombardment mass spectroscopy. Propionic acid also inhibited oxidation of [1-14C]palmitic acid (0.8 mM) by hepatocytes isolated from fed rats. The degree of inhibition caused by propionic acid was decreased in the presence of 10 mM-carnitine (41% inhibition in the absence of carnitine, 22% inhibition in the presence of carnitine). Propionic acid did not inhibit [1-14C]palmitic acid oxidation by hepatocytes isolated from 48 h-starved rats. These results demonstrate that propionic acid interferes with oxidative metabolism in intact hepatocytes. Carnitine partially reverses the inhibition of pyruvate and palmitic acid oxidation by propionic acid, and this reversal is associated with increased propionylcarnitine formation. The present study provides a metabolic basis for the efficacy of carnitine in patients with abnormal organic acid accumulation, and the observation that such patients appear to have increased carnitine requirements ('carnitine insufficiency').
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen R. J., Hansch D. B., Wu H. L. Hypocarnitinemia in disorders of organic acid metabolism. Lancet. 1982 Aug 28;2(8296):500–501. doi: 10.1016/s0140-6736(82)90532-3. [DOI] [PubMed] [Google Scholar]
- Berry M. N., Friend D. S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 1969 Dec;43(3):506–520. doi: 10.1083/jcb.43.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bohmer T., Bremer J. Propionylcarnitine. Physiological variations in vivo. Biochim Biophys Acta. 1968 May 1;152(3):559–567. doi: 10.1016/0005-2760(68)90096-9. [DOI] [PubMed] [Google Scholar]
- Brass E. P., Garrity M. J., Robertson R. P. Inhibition of glucagon-stimulated hepatic glycogenolysis by E-series prostaglandins. FEBS Lett. 1984 Apr 24;169(2):293–296. doi: 10.1016/0014-5793(84)80336-1. [DOI] [PubMed] [Google Scholar]
- Brass E. P., Hoppel C. L. Carnitine metabolism in the fasting rat. J Biol Chem. 1978 Apr 25;253(8):2688–2693. [PubMed] [Google Scholar]
- Brass E. P., Hoppel C. L. Effect of carnitine on mitochondrial oxidation of palmitoylearnitine. Biochem J. 1980 May 15;188(2):451–458. doi: 10.1042/bj1880451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brass E. P., Hoppel C. L. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J. 1980 Sep 15;190(3):495–504. doi: 10.1042/bj1900495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bremer J., Wojtczak A. B. Factors controlling the rate of fatty acid -oxidation in rat liver mitochondria. Biochim Biophys Acta. 1972 Dec 8;280(4):515–530. doi: 10.1016/0005-2760(72)90131-2. [DOI] [PubMed] [Google Scholar]
- Chalmers R. A., Roe C. R., Stacey T. E., Hoppel C. L. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res. 1984 Dec;18(12):1325–1328. doi: 10.1203/00006450-198412000-00021. [DOI] [PubMed] [Google Scholar]
- Christiansen R. Z. Regulation of palmitate metabolism by carnitine and glucagon in hepatocytes isolated from fasted and carbohydrate refed rats. Biochim Biophys Acta. 1977 Aug 24;488(2):249–262. doi: 10.1016/0005-2760(77)90182-5. [DOI] [PubMed] [Google Scholar]
- Christiansen R., Borrebaek B., Bremer J. The effect of (-)carnitine on the metabolism of palmitate in liver cells isolated from fasted and refed rats. FEBS Lett. 1976 Mar 1;62(3):313–317. doi: 10.1016/0014-5793(76)80083-x. [DOI] [PubMed] [Google Scholar]
- Di Donato S., Rimoldi M., Garavaglia B., Uziel G. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. Clin Chim Acta. 1984 May 16;139(1):13–21. doi: 10.1016/0009-8981(84)90187-6. [DOI] [PubMed] [Google Scholar]
- DiMarco J. P., Hoppel C. Hepatic mitochondrial function in ketogenic states. Diabetes, starvation, and after growth hormone administration. J Clin Invest. 1975 Jun;55(6):1237–1244. doi: 10.1172/JCI108042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glasgow A. M., Chase H. P. Effect of propionic acid on fatty acid oxidation and ureagenesis. Pediatr Res. 1976 Jul;10(7):683–686. doi: 10.1203/00006450-197607000-00010. [DOI] [PubMed] [Google Scholar]
- Gregersen N. Studies on the effects of saturated and unsaturated short-chain monocarboxylic acids on the energy metabolism of rat liver mitochondria. Pediatr Res. 1979 Nov;13(11):1227–1230. doi: 10.1203/00006450-197911000-00005. [DOI] [PubMed] [Google Scholar]
- Gregersen N. The specific inhibition of the pyruvate dehydrogenase complex from pig kidney by propionyl-CoA and isovaleryl-Co-A. Biochem Med. 1981 Aug;26(1):20–27. doi: 10.1016/0006-2944(81)90026-0. [DOI] [PubMed] [Google Scholar]
- Hoppel C. L., Genuth S. M. Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168–E172. doi: 10.1152/ajpendo.1982.243.2.E168. [DOI] [PubMed] [Google Scholar]
- Lopes-Cardozo M., Klazinga W., van den Bergh S. G. Accumulation of carnitine esters of beta-oxidation intermediates during palmitate oxidation by rat-liver mitochondria. Eur J Biochem. 1978 Feb;83(2):629–634. doi: 10.1111/j.1432-1033.1978.tb12132.x. [DOI] [PubMed] [Google Scholar]
- McGarry J. D., Robles-Valdes C., Foster D. W. Role of carnitine in hepatic ketogenesis. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4385–4388. doi: 10.1073/pnas.72.11.4385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McGarry J. D., Takabayashi Y., Foster D. W. The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. J Biol Chem. 1978 Nov 25;253(22):8294–8300. [PubMed] [Google Scholar]
- Millington D. S., Roe C. R., Maltby D. A. Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. Biomed Mass Spectrom. 1984 May;11(5):236–241. doi: 10.1002/bms.1200110508. [DOI] [PubMed] [Google Scholar]
- Myles D. D., Strong P., Sugden M. C. Errors arising from the use of [1-14C]pyruvate to measure flux through the liver pyruvate dehydrogenase complex. Biochem J. 1984 Mar 15;218(3):997–998. doi: 10.1042/bj2180997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olsen C. An enzymatic fluorimetric micromethod for the determination of acetoacetate, -hydroxybutyrate, pyruvate and lactate. Clin Chim Acta. 1971 Jul;33(2):293–300. doi: 10.1016/0009-8981(71)90486-4. [DOI] [PubMed] [Google Scholar]
- Roe C. R., Hoppel C. L., Stacey T. E., Chalmers R. A., Tracey B. M., Millington D. S. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child. 1983 Nov;58(11):916–920. doi: 10.1136/adc.58.11.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe C. R., Millington D. S., Maltby D. A., Bohan T. P., Hoppel C. L. L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest. 1984 Jun;73(6):1785–1788. doi: 10.1172/JCI111387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roe C. R., Millington D. S., Maltby D. A., Kahler S. G., Bohan T. P. L-carnitine therapy in isovaleric acidemia. J Clin Invest. 1984 Dec;74(6):2290–2295. doi: 10.1172/JCI111657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seccombe D. W., Snyder F., Parsons H. G. L-carnitine for methylmalonicaciduria. Lancet. 1982 Dec 18;2(8312):1401–1401. doi: 10.1016/s0140-6736(82)91300-9. [DOI] [PubMed] [Google Scholar]
- Solberg H. E., Bremer J. Formation of branched chain acylcarnitines in mitochondria. Biochim Biophys Acta. 1970 Nov 24;222(2):372–380. doi: 10.1016/0304-4165(70)90126-1. [DOI] [PubMed] [Google Scholar]
- Stumpf D. A., McAfee J., Parks J. K., Eguren L. Propionate inhibition of succinate:CoA ligase (GDP) and the citric acid cycle in mitochondria. Pediatr Res. 1980 Oct;14(10):1127–1131. doi: 10.1203/00006450-198010000-00008. [DOI] [PubMed] [Google Scholar]
- Stumpf D. A., Parker W. D., Jr, Angelini C. Carnitine deficiency, organic acidemias, and Reye's syndrome. Neurology. 1985 Jul;35(7):1041–1045. doi: 10.1212/wnl.35.7.1041. [DOI] [PubMed] [Google Scholar]
- Sugiyama N., Morishita H., Nagaya S., Nakajima T., Kawase A., Ohya A., Sugiyama S., Kamiya K., Watanabe I., Togari H. Biochemical evidence of carnitine effect on propionate elimination. J Inherit Metab Dis. 1984;7(3):137–138. doi: 10.1007/BF01801775. [DOI] [PubMed] [Google Scholar]
- Valkner K. J., Bieber L. L. Short-chain acylcarnitines of human blood and urine. Biochem Med. 1982 Oct;28(2):197–203. doi: 10.1016/0006-2944(82)90070-9. [DOI] [PubMed] [Google Scholar]